Log In
BCIQ
Print this Print this
 

IBL-202

  Manage Alerts
Collapse Summary General Information
Company Inflection Biosciences Ltd.
DescriptionPIM and PI3K inhibitor
Molecular Target Pim-1 (PIM1) ; Phosphoinositide 3-kinase (PI3K)
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today